Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

ContraFect Corporation CFRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
18/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

ContraFect Corporation (CFRX) has 12 identified peers for comparison in the Healthcare sector. Peers include ALLR, CNSP, DRMA, FWBI, HILS, NRBO and others.

People Also View

PALI
PALI
Palisade Bio, Inc.
$2.34
+13.59%
 UNCY
UNCY
Unicycive Therapeutics, Inc.
$6.97
+0.43%
 NRBO
NRBO
NeuroBo Pharmaceuticals, Inc.
$2.36
+0.00%
 ALLR
ALLR
Allarity Therapeutics, Inc.
$1.25
+5.04%
 FWBI
FWBI
First Wave BioPharma, Inc.
$2.96
+4.59%
 REVB
REVB
Revelation Biosciences, Inc.
$1.26
+5.00%
 HILS
HILS
Hillstream BioPharma, Inc.
$0.24
+5.66%
 QNRX
QNRX
Quoin Pharmaceuticals, Ltd.
$6.49
+3.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message